Anti-Human C5 Therapeutic Antibody (Olendalizumab)

Recombinant monoclonal antibody to C5. Olendalizumab is a humanized monoclonal antibody that can be potentially used in the treatment of Graft-versus-host disease, Antiphospholipid syndrome.
Supplier Creative Biolabs
Product # TAB-436CQ
Pricing Inquiry
Host Human
Target C5
Species Reactivity Human
Type IgG4, κ
Applications Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Functional Studies
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback